FATE – Fate Therapeutics, Inc.
FATE
$1.07Name : Fate Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $122,657,320.00
EPSttm : -1.49
Fate Therapeutics, Inc.
$1.07
Float Short %
8.83
Margin Of Safety %
Put/Call OI Ratio
0.08
EPS Next Q Diff
-0.01
EPS Last/This Y
0.35
EPS This/Next Y
0.14
Price
1.07
Target Price
5.36
Analyst Recom
2.36
Performance Q
-13.71
Relative Volume
0.43
Beta
2.24
Ticker: FATE
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-07-04 | FATE | 1.13 | 0.07 | 10.00 | 6424 |
2025-07-07 | FATE | 1.065 | 0.07 | 0.00 | 6425 |
2025-07-08 | FATE | 1.09 | 0.07 | 1.84 | 6439 |
2025-07-09 | FATE | 1.145 | 0.08 | 0.00 | 6578 |
2025-07-10 | FATE | 1.16 | 0.08 | 0.00 | 6785 |
2025-07-11 | FATE | 1.145 | 0.08 | 0.00 | 7134 |
2025-07-14 | FATE | 1.145 | 0.08 | 0.00 | 7093 |
2025-07-15 | FATE | 1.14 | 0.07 | 0.00 | 7498 |
2025-07-16 | FATE | 1.13 | 0.07 | 0.00 | 7595 |
2025-07-17 | FATE | 1.155 | 0.07 | 0.00 | 7594 |
2025-07-18 | FATE | 1.135 | 0.07 | 0.02 | 7806 |
2025-07-21 | FATE | 1.145 | 0.07 | 0.00 | 6205 |
2025-07-22 | FATE | 1.24 | 0.07 | 0.00 | 6281 |
2025-07-23 | FATE | 1.27 | 0.07 | 0.11 | 6169 |
2025-07-24 | FATE | 1.245 | 0.07 | 0.03 | 6468 |
2025-07-25 | FATE | 1.235 | 0.07 | 0.62 | 6450 |
2025-07-28 | FATE | 1.305 | 0.08 | 0.00 | 6545 |
2025-07-29 | FATE | 1.16 | 0.08 | 0.29 | 6629 |
2025-07-30 | FATE | 1.135 | 0.08 | 0.00 | 6632 |
2025-07-31 | FATE | 1.1 | 0.08 | 0.00 | 6739 |
2025-08-01 | FATE | 1.065 | 0.08 | 0.00 | 6731 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-07-04 | FATE | 1.12 | -1.4 | - | -1.24 |
2025-07-07 | FATE | 1.07 | -1.4 | - | -1.24 |
2025-07-08 | FATE | 1.09 | -1.4 | - | -1.24 |
2025-07-09 | FATE | 1.15 | -1.4 | - | -1.24 |
2025-07-10 | FATE | 1.16 | -1.4 | - | -1.24 |
2025-07-11 | FATE | 1.15 | -1.4 | - | -1.24 |
2025-07-14 | FATE | 1.15 | -1.4 | - | -1.24 |
2025-07-15 | FATE | 1.13 | -1.4 | - | -1.24 |
2025-07-16 | FATE | 1.13 | -1.4 | - | -1.24 |
2025-07-17 | FATE | 1.15 | -1.4 | - | -1.24 |
2025-07-18 | FATE | 1.14 | -1.4 | - | -1.24 |
2025-07-21 | FATE | 1.15 | -1.4 | - | -1.24 |
2025-07-22 | FATE | 1.24 | -1.4 | - | -1.24 |
2025-07-23 | FATE | 1.28 | -1.4 | - | -1.24 |
2025-07-24 | FATE | 1.25 | -1.4 | - | -1.24 |
2025-07-25 | FATE | 1.24 | -1.4 | - | -1.24 |
2025-07-28 | FATE | 1.30 | -1.4 | - | -1.24 |
2025-07-29 | FATE | 1.17 | -1.4 | - | -1.24 |
2025-07-30 | FATE | 1.14 | -1.4 | - | -1.24 |
2025-07-31 | FATE | 1.10 | -1.4 | - | -1.24 |
2025-08-01 | FATE | 1.07 | -4.3 | - | -1.29 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-07-04 | FATE | -0.27 | -6.16 | 8.88 |
2025-07-07 | FATE | -0.27 | -6.17 | 8.88 |
2025-07-08 | FATE | -0.27 | -6.17 | 8.88 |
2025-07-09 | FATE | -0.27 | -6.17 | 8.88 |
2025-07-10 | FATE | -0.27 | -6.17 | 8.88 |
2025-07-11 | FATE | -0.27 | -6.17 | 8.91 |
2025-07-14 | FATE | 0.00 | -6.14 | 8.91 |
2025-07-15 | FATE | 0.00 | -6.14 | 8.91 |
2025-07-16 | FATE | 0.00 | -6.14 | 8.91 |
2025-07-17 | FATE | 0.00 | -6.14 | 8.91 |
2025-07-18 | FATE | 0.00 | -6.14 | 8.91 |
2025-07-21 | FATE | 0.00 | -6.36 | 8.91 |
2025-07-22 | FATE | 0.00 | -6.36 | 8.91 |
2025-07-23 | FATE | 0.00 | -6.36 | 8.91 |
2025-07-24 | FATE | 0.00 | -6.36 | 8.91 |
2025-07-25 | FATE | 0.00 | -6.36 | 8.83 |
2025-07-28 | FATE | 0.00 | -6.03 | 8.83 |
2025-07-29 | FATE | 0.00 | -6.03 | 8.83 |
2025-07-30 | FATE | 0.00 | -6.03 | 8.83 |
2025-07-31 | FATE | 0.00 | -6.03 | 8.83 |
2025-08-01 | FATE | 0.00 | -6.03 | 8.83 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.32
Avg. EPS Est. Current Quarter
-0.33
Avg. EPS Est. Next Quarter
-0.33
Insider Transactions
Institutional Transactions
-6.03
Beta
2.24
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
15
Growth Score
28
Sentiment Score
1
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.4
Target Price
5.36
P/E
Forward P/E
PEG
P/S
9.19
P/B
0.43
P/Free Cash Flow
EPS
-1.49
Average EPS Est. Cur. Y
-1.29
EPS Next Y. (Est.)
-1.15
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1318.93
Relative Volume
0.43
Return on Equity vs Sector %
-84.7
Return on Equity vs Industry %
-66.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 181
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading